Nodal follicular helper T-cell-derived lymphoproliferations (specifically the less common peripheral T-cell lymphomas of follicular type) exhibit a spectrum of histologic features that may mimic reactive hyperplasia or Hodgkin lymphoma. Even though angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma of follicular type share a common biologic origin from follicular helper T-cells and their morphology has been well characterized, flow cytometry of peripheral T-cell lymphomas of follicular type has not been widely discussed as a tool for identifying this reactive hyperplasia/Hodgkin lymphoma mimic. We identified 10 peripheral T-cell lymphomas of follicular type with available flow cytometry data from five different institutions, including two cases with peripheral blood evaluation. For comparison, we examined flow cytometry data for 8 classical Hodgkin lymphomas (including 1 lymphocyte-rich classical Hodgkin lymphoma), 15 nodular lymphocyte predominant Hodgkin lymphomas, 15 angioimmunoblastic T-cell lymphomas, and 26 reactive nodes. Lymph node histology and flow cytometry data were reviewed, specifically for the presence of a CD3 − /dim CD4 + aberrant T-cell population (described in angioimmunoblastic T-cell lymphomas), besides other T-cell aberrancies. Nine of 10 (90%) peripheral T-cell lymphomas of follicular type showed a CD3 − /dim CD4 + T-cell population constituting 29.3% (range 7.9-62%) of all lymphocytes. Five of 10 (50%) had nodular lymphocyte predominant Hodgkin lymphoma or lymphocyte-rich classical Hodgkin lymphoma-like morphology with scattered Hodgkin-like cells that expressed CD20, CD30, CD15, and MUM1. Three cases had a nodular growth pattern and three others exhibited a perifollicular growth pattern without Hodgkin-like cells. Epstein-Barr virus was positive in 1 of 10 cases (10%). PCR analysis showed clonal T-cell receptor gamma gene rearrangement in all 10 peripheral T-cell lymphomas of follicular type. By flow cytometry, 11 of 15 (73.3%) angioimmunoblastic T-cell lymphomas showed the CD3 − /dim CD4 + population (mean: 19.5%, range: 3-71.8%). Using a threshold of 3% for CD3 − /dim CD4 + T cells, all 15 nodular lymphocyte predominant Hodgkin lymphoma controls and 8 classical Hodgkin lymphomas were negative (Mann-Whitney P = 0.01, F-PTCL vs Hodgkin lymphomas), as were 25 of 26 reactive lymph nodes. The
Nodal follicular helper T-cell-derived lymphoproliferations (specifically the less common peripheral T-cell lymphomas of follicular type) exhibit a spectrum of histologic features that may mimic reactive hyperplasia or Hodgkin lymphoma. Even though angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma of follicular type share a common biologic origin from follicular helper T-cells and their morphology has been well characterized, flow cytometry of peripheral T-cell lymphomas of follicular type has not been widely discussed as a tool for identifying this reactive hyperplasia/Hodgkin lymphoma mimic. We identified 10 peripheral T-cell lymphomas of follicular type with available flow cytometry data from five different institutions, including two cases with peripheral blood evaluation. For comparison, we examined flow cytometry data for 8 classical Hodgkin lymphomas (including 1 lymphocyte-rich classical Hodgkin lymphoma), 15 nodular lymphocyte predominant Hodgkin lymphomas, 15 angioimmunoblastic T-cell lymphomas, and 26 reactive nodes. Lymph node histology and flow cytometry data were reviewed, specifically for the presence of a CD3 − /dim CD4 + aberrant T-cell population (described in angioimmunoblastic T-cell lymphomas), besides other T-cell aberrancies. Nine of 10 (90%) peripheral T-cell lymphomas of follicular type showed a CD3 − /dim CD4 + T-cell population constituting 29.3% (range 7.9-62%) of all lymphocytes. Five of 10 (50%) had nodular lymphocyte predominant Hodgkin lymphoma or lymphocyte-rich classical Hodgkin lymphoma-like morphology with scattered Hodgkin-like cells that expressed CD20, CD30, CD15, and MUM1. Three cases had a nodular growth pattern and three others exhibited a perifollicular growth pattern without Hodgkin-like cells. Epstein-Barr virus was positive in 1 of 10 cases (10%). PCR analysis showed clonal T-cell receptor gamma gene rearrangement in all 10 peripheral T-cell lymphomas of follicular type. By flow cytometry, 11 of 15 (73.3%) angioimmunoblastic T-cell lymphomas showed the CD3 − /dim CD4 + population (mean: 19.5%, range: 3-71.8%). Using a threshold of 3% for CD3 − /dim CD4 + T cells, all 15 nodular lymphocyte predominant Hodgkin lymphoma controls and 8 classical Hodgkin lymphomas were negative (Mann-Whitney P = 0.01, F-PTCL vs Hodgkin lymphomas), as were 25 of 26 reactive lymph nodes. The high frequency of CD3 − /dim CD4 + aberrant T cells is similar in angioimmunoblastic T-cell lymphomas and peripheral T-cell lymphomas of follicular type, and is a useful feature in distinguishing peripheral T-cell lymphomas of follicular type from morphologic mimics such as reactive hyperplasia or Hodgkin lymphoma. Peripheral T-cell lymphomas of follicular type 1,2 are one of the several novel forms of peripheral T-cell lymphomas recognized in the last decade. Although a relationship between peripheral T-cell lymphoma of follicular type and angioimmunoblastic T-cell lymphoma was suspected based on morphologic similarities, it was not until significant advances were made in the understanding of follicular helper T-cell biology 3, 4 that it became apparent that both angioimmunoblastic T-cell lymphoma and the peripheral T-cell lymphoma of follicular type share a common biologic derivation from follicular helper T cells. 5, 6 Typical angioimmunoblastic T-cell lymphomas are often straightforward to recognize, given the characteristic morphologic features (vascular arborization, dilated peripheral cortical sinus, clear cells, and extrafollicular dendritic cell meshworks), and ancillary flow cytometry or molecular genetic studies are often not needed. However, a proportion angioimmunoblastic T-cell lymphomas exhibit unusual cytologic features, including: (1) associated Hodgkin-like cells of a B-lineage derivation variably expressing EBV; 7 and (2) early 'reactive hyperplasia' growth pattern (so-called 'pattern 1') described by Attygalle co-workers. 8, 9 These reports expand our understanding of the range of histologic patterns that may be observed in angioimmunoblastic T-cell lymphomas and additionally serve to highlight that some cases may be difficult to distinguish from either reactive conditions or Hodgkin lymphoma. Similar difficulties may be encountered with peripheral T-cell lymphomas of follicular type, as evidenced by the recent series of cases described by Moroch et al, demonstrating striking resemblance to Hodgkin lymphoma. 10 Thus, better ancillary tools are needed to distinguish these entities.
Existing literature on flow cytometry in angioimmunoblastic T-cell lymphomas describes the classic occurrence of two distinct atypical T-cell populations, including CD3 + /CD10 + co-expressing T cells, and a CD3 − /dim CD4 + population that is not as well recognized. The latter population was initially described by Serke et al 11 and although not routinely assessed in daily practice, it is nevertheless reported to be frequently present in angioimmunoblastic T-cell lymphoma in over 50% of cases, 8, [12] [13] [14] with a recent report demonstrating its detection in nearly 100% of cases. 15 We thus undertook this study to assess these two T-cell populations, in cases of peripheral T-cell lymphomas of follicular type because in spite of the number of reports detailing histologic findings, 6, 10 there is limited literature on the flow cytometric characteristics of this entity. On one hand, we sought to compare these cases to angioimmunoblastic T-cell lymphoma to further explore the relationship between these two neoplasms. In addition, we also investigated control cases that included nonneoplastic lymphadenopathy, as well as both classical Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma to determine if identification of these T-cell populations could aid in the distinction of angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma of follicular type from Hodgkin lymphoma and reactive hyperplasia.
Materials and methods
We retrospectively identified 10 well-characterized cases of peripheral T-cell lymphoma of follicular type with available multi-parameter flow cytometry data from five institutions, none of which had any features of overt angioimmunoblastic T-cell lymphoma. The histologic findings on formalin-fixed paraffin embedded tissues were reviewed and the diagnosis was confirmed using a comprehensive immunohistochemistry panel including: CD20, CD3, CD4, CD8, CD5, CD7, CD2, ICOS, and CXCL13, and PD1. PCR for T-cell receptor gamma gene rearrangement (TRG) was performed in all cases by the respective institutions. This study was approved by the the University of Chicago Medicine Institutional Review Board (IRB#1133), as well as by the IRBs of the collaborating institutions. Parts of the data reported in cases 1-4 were published in separate reports previously.
Multi-parameter flow cytometry was performed on equivalent 4-, 5-, 6-, or 8-color instruments by the participating institutions, including a comprehensive panel targeting T-cell antigens. Testing was performed on lymph node samples when available. Peripheral blood was analyzed in cases 3 and 4. Bone marrow aspirate was studied in case 2, in addition to the lymph node. For analysis, cell populations were gated according to characteristic CD45 vs side scatter properties for primary gating of lymphocytes. Specifically, list mode files were evaluated using either CXP, CellQuest, Paint-a-Gate (Becton Dickinson), or Kaluza v1.2 software (Beckman Coulter, Brea, CA, USA) to assess angioimmunoblastic T-cell lymphoma-specific T-cell aberrancies, including (1) the presence of a CD3 − /dim CD4 + T-cell Flow of T FH PTCLs population; (2) CD3 + /CD10 + co-expression; and (3) T-cell antigen loss including CD2, CD5, or CD7. List mode files were re-evaluated for all cases, where files were available for review.
Normal lymphoid cells within specimens served as internal positive and negative controls (eg, B cells served as negative controls for T-cell-directed antibodies), as well as for antibody-binding intensity. Although no definitive cutoff was used for intensity of expression, bright expression was defined as higher expression than normal T cells, whereas dim expression was defined as lower expression than that observed in normal T cells in concordance with the 1997 US-Canadian consensus guidelines 16 and 2006 Bethesda International Consensus Guidelines. 17 Partial expression was defined as a sub-population of neoplastic cells staining more intensely with an antibody than observed in the internal negative control cells.
Controls Cases
For comparison, 15 typical angioimmunoblastic T-cell lymphomas (reviewed by K.I, M.P.M, G.V, A. S.D, and M.J.B) and 8 typical classical Hodgkin lymphoma cases (reviewed by G.V. and M.A.) were analyzed at the University of Chicago using the FC500 flow cytometer for acquisition (Beckman Coulter). An additional confirmatory tube (CD45/ CD19/CD3/CD4/CD14) was performed in one classical Hodgkin lymphoma case to ascertain that we were not misinterpreting monocytes (CD3 − CD4 dim ) as an abnormal lymphoid population. In this analysis, we observed no monocyte contamination and thereafter concluded that CD45 vs side scatter itself afforded sufficient exclusion of monocytes expressing dimmer CD4 compared with T cells. In addition, 15 nodular lymphocyte predominant Hodgkin lymphoma cases and 26 reactive lymphoid tissues representing a variety of histologic patterns were examined using the FACSCalibur flow cytometer with data acquisition using CellQuest software (BD Biosciences, San Jose, CA, USA).
Statistical Analysis
Basic descriptive statistics comparing median percentages between two groups (Wilcoxon rank-sum test) were performed using Stata 11 (Statacorp, College Station, TX, USA). 
Results

Diagnosis and Characterization of Peripheral T-Cell Lymphoma of Follicular Type Cases
Flow Cytometry Findings in Peripheral T-Cell Lymphomas of Follicular Type
Flow cytometry findings are summarized in Table 1 . In 9 of 10 (90%) cases, we identified a distinct population of CD3 − /dim CD4 + T cells that constituted a mean of 29.3% (range 7.9-62%) of all lymphocytes gated (Figures 1 and 2) . A normal population of CD3 + T cells was also present in all cases. Both CD3 − /dim and CD3 + subsets expressed pan-T-cell markers CD2 and CD5. CD7 was lost in 1 of 10 cases. For two cases in which B cells were examined further, we did not identify any associated monotypic B-cell population. Flow cytometry on cases 3 and 4 was performed on peripheral blood specimens, although the remaining cases were done on involved lymph nodes. Case 2 showed bone marrow involvement by the CD3 − /dim CD4 + population, although morphologic evidence of bone marrow involvement was not present. Peripheral blood was not tested in this case. There was no correlation between the percentages of CD3 − /dim CD4 + T cells and the presence of morphologic features approximating typical/advanced angioimmunoblastic T-cell lymphoma. CD10 expression on the atypical T-cell population by flow cytometry was restricted only to the three cases with a perifollicular histologic growth pattern, two of which also harbored a distinct CD3 − /dim CD4 + T-cell population. CD10 expression was absent in all cases with a nodular growth pattern. Figure 4 ). T cells were predominantly CD4 + , with an average CD4:CD8 ratio of 3.7. Ten of 15 cases showed loss of CD7, with normal expression of CD2 and CD5 in all cases. In another case without CD3 and CD4 in one tube, we observed a small CD3 − /CD5 + population negative for CD19. This population of 3% of all lymphocytes was identified in another tube based on the CD3 + /CD2 + /CD7 − phenotype to be exclusively CD4 + . By flow cytometry, all eight classical Hodgkin lymphomas showed CD4 + T-cell predominance with an average CD4:CD8 ratio of 3.2. All showed o 2% CD3 − /dim CD4 + T cells (mean 0.45% of all lymphocytes; range 0-1.9%). For assessment of CD10 coexpression on T cells, CD5 was used as a surrogate for CD3 + T cells, as a separate tube combining CD3 with CD10 was not available. CD5 + /CD10 + populations were minimal in all eight cases analyzed (mean 2.9% of lymphocytes, range 0-9%), without distinct clusters in the dot plots. These cells were not CD19 + B cells.
Flow Cytometry Findings of Control Angioimmunoblastic T-Cell Lymphoma, Hodkgin Lymphoma, and Reactive Hyperplasia Cases
The 15 nodular lymphocyte predominant Hodgkin lymphomas showed CD4 + T-cell predominance with a CD4:CD8 ratio of 4.1. The CD3 − /dim CD4 + T-cell Flow of T FH PTCLs population was minimal, averaging 0.73% of the total lymphocyte population in these cases (range: 0.05-1.43%) did not form distinct clustering in the dot plots. Ten of 15 cases showed a significant (43%) population of dual CD4 + /CD8 + T cells, described previously as a characteristic flow cytometric finding in nodular lymphocyte predominant Hodgkin lymphoma. 19 Of the 26 reactive lymphoid tissues examined by FC, the CD3 − /dim CD4 + T-cell averaged 1.2% of the total lymphocyte population (range: 0.19-3.0%). Histologic finding in some of these included follicular hyperplasia (n = 8, including two with wellcontrolled human immunodeficiency virus infection), progressive transformation of germinal centers (n = 3), and others with a non-specific mixed pattern.
Discussion
In this study, we present flow cytometry findings from histologically well-characterized peripheral T-cell lymphomas of follicular type, including three perifollicular cases and five with a nodular pattern, resembling classical Hodgkin lymphoma/nodular lymphocyte predominant Hodgkin lymphoma. We identified the frequent presence of a CD3 − /dim CD4 + T-cell population in 90% of peripheral T-cell lymphomas of follicular type, a similar frequency to that reported in angioimmunoblastic T-cell lymphomas, in keeping with their common origin from follicular helper T cells. A smaller proportion of peripheral T-cell lymphomas of follicular type in our series (30%) showed CD3/CD10 co-expression, a feature reported in over 80% of angioimmunoblastic T-cell lymphoma cases. 20 This finding appeared to be restricted to cases with a perifollicular growth pattern, and was not seen in cases with nodular growth and Hodgkin/Reed-Sternberg-like cells.
de Leval and co-workers first described three cases of peripheral T-cell lymphomas with a striking nodular or predominant follicular growth pattern associated with follicular dendritic cell meshworks. 2 The authors noted that these cases were distinct from bona fide angioimmunoblastic T-cell lymphomas owing to the lack of the vascularity, extrafollicular dendritic cell meshworks, and absence of B-cell blasts. By immunohistochemistry, these tumors were described as having a CD3 + CD4 + phenotype. The difference between immunophenotypic findings by immunohistochemistry vs flow cytometry may be related to the detection of cytoplasmic, but not surface CD3 with the former technique. In one of the cases in that series, flow cytometry was performed although CD3 − CD4 + cells were not described. Since then, flow cytometry data was not reported or discussed in subsequent larger series on peripheral T-cell lymphomas of follicular type. 6, 21 Diagnosis of peripheral T-cell lymphomas may be difficult and there are two specific situations, in which our findings can contribute to more accurate diagnosis. The first is in cases of early angioimmunoblastic T-cell lymphomas with a reactive hyperplasia pattern, wherein the neoplastic follicular helper T-cell proliferation is restricted topographically to the perifollicular regions in the vicinity of the perifollicular sinus with largely preserved germinal center architecture; such cases may be misinterpreted as a benign process if this focal proliferation is overlooked. The second situation is a predominantly nodular lymphoproliferation with or without associated CD30 ± and/or CD20 + Hodgkin/Reed-Sternberg-like cells, in which the differential diagnosis includes both peripheral T-cell lymphoma of follicular type and Hodgkin lymphoma, including nodular lymphocyte predominant Hodgkin lymphoma and lymphocyte-rich classical Hodgkin lymphoma.
In reference to the former situation, cases of peripheral T-cell lymphomas of follicular type with a reactive perifollicular growth pattern have been reported previously 1, 9, 21 and may be misinterpreted as a reactive follicular hyperplasia owing to the relative preservation of nodal architecture in such cases. Although our series is small, it is notable that two of three cases with the perifollicular pattern showed the CD3 − /dim CD4 + T-cell population. Although all three cases demonstrated an aberrant CD3 + CD10 + T-cell population, recent data indicates that CD10 expression may be less specific in as much as certain normal T-cells subsets (in reactive nodes, as well as some B-cell lymphomas) may express CD10. 22, 23 In one of the larger series examining 10 angioimmunoblastic T-cell lymphomas with a perifollicular 'pattern 1' morphology, flow cytometry findings were not available. 9 More recent larger series reporting flow cytometry data on angioimmunoblastic T-cell lymphomas focus only on the sensitivity and specificity of the CD3 + CD10 + T-cell population for an overt angioimmunoblastic T-cell lymphoma phenotype and did not include cases of peripheral T-cell lymphomas of follicular type with either follicular or perifollicular growth patterns. 15 Challenges in making a diagnosis of peripheral T-cell lymphoma of follicular type include its predominant nodular growth pattern and the occasional presence of Hodgkin/Reed-Sternberg-like cells that raise the differential diagnosis of nodular lymphocyte predominant Hodgkin lymphoma or lymphocyte-rich classical Hodgkin lymphoma with a nodular growth pattern (so-called 'follicular Hodgkin's disease' described by Ashton-Key et al). 24 In our series, cases 2, 5, and 6 were initially diagnosed as Hodgkin lymphoma, but molecular studies confirmed the diagnosis of a peripheral T-cell lymphoma. On the basis of our findings, we would like to suggest the use of a flow cytometry panel comprising CD3, CD14, CD4, CD5, and CD10. Although a basic panel with CD3/CD4/CD8/CD10 would likely be sufficient in making the diagnosis, the combination with the addition of CD14 and CD5, helps to identify CD3 − /dim CD4 + T cells, excludes possible monocytic derivation of this population, and identifies CD3 + CD10 + T cells, whereas the pan-T-cell antigen CD5 would pick up the CD3-negative T-cell population. Although the absence of the CD3 − /dim CD4 population does not exclude a follicular helper T-cell proliferation, its presence at 43% of all lymphocytes in a lymphoma histologically resembling Hodgkin lymphoma should certainly lead one to question the diagnosis of Hodgkin lymphoma and prompt further molecular genetic studies for the presence of a clonal T-cell gene rearrangement.
Our study demonstrates that identification of this characteristic CD3 − /dim CD4 + T-cell population can be helpful in peripheral T-cell lymphomas with either a reactive hyperplasia-like or a nodular Hodgkin-like growth pattern. Our results are consistent with the growing evidence that the CD3 − /dim CD4 + T-cell population is frequently associated with an angioimmunoblastic T-cell lymphoma phenotype, observed in 50-100% of cases in prior series. 15, 25, 26 Given our finding of this population in the great majority of cases of peripheral T-cell lymphoma of follicular type, our results further emphasize the relationship between these two entities, although others have shown that there may be some unique molecular genetic differences between angioimmunoblastic T-cell lymphoma and non-angioimmunoblastic T-cell lymphoma follicular helper T-cell proliferations. [27] [28] [29] One limitation of our study is that it is a retrospective analysis of flow cytometry data collected from multiple institutions and not all T-cell marker combinations could be uniformly examined on all cases via flow cytometry. Nevertheless, the fact that similar findings were detected in cases diagnosed at several different laboratories using various flow cytometry methodologies suggests the widespread utility of this population in supporting a diagnosis of peripheral T-cell lymphoma of follicular helper T-cell derivation. The diagnosis typically requires immunostains to demonstrate a follicular helper T-cell phenotype, such as PD1, CXCL13, and ICOS. 30, 31 Although the diagnosis of peripheral T-cell lymphoma of follicular type requires the confirmation of follicular helper T-cell derivation through expression of follicular helper T-cell-specific markers, these antibodies may not be routinely available in all laboratories; however, flow cytometry can be readily performed in such cases using commonly available antibodies such as CD3, CD4, and CD10, allowing for more rapid evaluation of these challenging cases. It also provides an important clue for the pathologist and would prompt the ordering of the follicular helper T-cell markers needed to make the diagnosis.
In summary, our findings demonstrate that a CD3 − /dim CD4 + T-cell population is commonly found in cases of peripheral T-cell lymphomas of follicular type and angioimmunoblastic T-cell lymphomas, further supporting the relationship between these two follicular helper T-cell-derived neoplasms. In both sets of cases, the CD3 − /dim CD4 + T-cell population was more frequently identified than a CD3 + CD10 + co-expressing population, and was absent or rare in control cases of Hodgkin lymphoma and reactive hyperplasia, underscoring its utility as a clue to the diagnosis of a peripheral T-cell lymphoma of follicular helper T-cell derivation, particularly in cases with morphologic and immunophenotypic features mimicking Hodgkin lymphoma. Hence, we strongly recommend performing flow cytometry in all cases morphologically resembling nodular lymphocyte predominant Hodgkin lymphoma or lymphocyte-rich classical Hodgkin lymphoma on initial evaluation, to exclude the possibility of a peripheral T-cell lymphoma of follicular helper T-cell derivation.
